ES2161883T3 - Compuestos y metodos para la estimulacion y aumento de las respuestas inmunes protectoras y la produccion de il-2. - Google Patents
Compuestos y metodos para la estimulacion y aumento de las respuestas inmunes protectoras y la produccion de il-2.Info
- Publication number
- ES2161883T3 ES2161883T3 ES95918291T ES95918291T ES2161883T3 ES 2161883 T3 ES2161883 T3 ES 2161883T3 ES 95918291 T ES95918291 T ES 95918291T ES 95918291 T ES95918291 T ES 95918291T ES 2161883 T3 ES2161883 T3 ES 2161883T3
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- production
- methods
- stimulation
- increase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 108010002350 Interleukin-2 Proteins 0.000 title 1
- 230000001681 protective effect Effects 0.000 title 1
- 230000000638 stimulation Effects 0.000 title 1
- 102000005877 Peptide Initiation Factors Human genes 0.000 abstract 1
- 108010044843 Peptide Initiation Factors Proteins 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/008—Leishmania antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE PRESENTAN COMPUESTOS Y METODOS PARA ESTIMULAR E INTENSIFICAR LAS RESPUESTAS INMUNES Y PARA EVALUAR LAS RESPUESTAS INMUNES DE UN PACIENTE. SE PRESENTAN COMPUESTOS QUE INCLUYEN POLIPEPTIDOS QUE CONTIENE AL MENOS UNA PORCION BIOLOGICAMENTE ACTIVA DE UN HOMOLOGO LESHMANIA BRAZILIENSIS DEL FACTOR DE INICIACION EUCARIOTICO 4A, O DE UNA VARIANTE DEL MISMO. TALES COMPUESTOS SON UTILES PARA ESTIMULAR UNA RESPUESTA INMUNE A LA TH1 Y PARA LA PRODUCCION IL SHMANIASIS U OTROS TRASTORNOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23253494A | 1994-04-22 | 1994-04-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2161883T3 true ES2161883T3 (es) | 2001-12-16 |
Family
ID=22873521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95918291T Expired - Lifetime ES2161883T3 (es) | 1994-04-22 | 1995-04-24 | Compuestos y metodos para la estimulacion y aumento de las respuestas inmunes protectoras y la produccion de il-2. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5876966A (es) |
EP (1) | EP0804581B1 (es) |
JP (1) | JP3350551B2 (es) |
KR (1) | KR100358271B1 (es) |
CN (1) | CN1149887A (es) |
AT (1) | ATE206163T1 (es) |
AU (1) | AU695273B2 (es) |
BR (1) | BR9507505A (es) |
CA (1) | CA2188543A1 (es) |
DE (1) | DE69522965T2 (es) |
ES (1) | ES2161883T3 (es) |
NO (1) | NO964468L (es) |
NZ (1) | NZ285238A (es) |
PT (1) | PT804581E (es) |
WO (1) | WO1995029239A2 (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5876735A (en) * | 1994-04-22 | 1999-03-02 | Corixa Corporation | Methods for enhancement of protective immune responses |
US6013268A (en) * | 1994-04-22 | 2000-01-11 | Corixa Corporation | Methods for enhancement of protective immune responses |
US5879687A (en) * | 1994-04-22 | 1999-03-09 | Corixa Corporation | Methods for enhancement of protective immune responses |
US6375955B1 (en) | 1995-09-22 | 2002-04-23 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US5834592A (en) | 1995-09-22 | 1998-11-10 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
US6500437B1 (en) | 1995-09-22 | 2002-12-31 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US6365165B1 (en) | 1995-09-22 | 2002-04-02 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
US6607731B1 (en) | 1995-09-22 | 2003-08-19 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US6638517B2 (en) | 1995-09-22 | 2003-10-28 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US6613337B1 (en) | 1997-02-12 | 2003-09-02 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US6020144A (en) | 1996-09-12 | 2000-02-01 | Symbiontics, Inc. | Sustained delivery device comprising a Leishmania protozoa and methods of making and using the same |
BR9807332A (pt) * | 1997-02-12 | 2000-10-31 | Corixa Corp | Antìgenos de leishmania para utilização na terapia e diagnóstico de leishmaniose |
EP1113073A3 (en) * | 1997-02-12 | 2003-05-14 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US6517839B1 (en) | 1997-07-18 | 2003-02-11 | The Regents Of The University Of California | Methods for inducing interleukin-12 and a type1/Th1 T-cell response |
US6630179B1 (en) * | 1998-09-23 | 2003-10-07 | Enerkom (Proprietary) Limited | Oxihumic acid and its use in the treatment of various conditions |
US6902734B2 (en) | 2000-08-07 | 2005-06-07 | Centocor, Inc. | Anti-IL-12 antibodies and compositions thereof |
US6892140B1 (en) * | 2000-11-27 | 2005-05-10 | Enteron, Inc. | Immunogenic cancer peptides and uses thereof |
IL155812A0 (en) * | 2000-12-07 | 2003-12-23 | Lilly Co Eli | Glp-1 fusion proteins |
US20020193295A1 (en) * | 2001-05-04 | 2002-12-19 | Emanuel Calenoff | Immunogenic peptides and uses thereof |
US20070161087A1 (en) * | 2003-05-29 | 2007-07-12 | Wolfgang Glaesner | Glp-1 fusion proteins |
WO2005062770A2 (en) * | 2003-12-19 | 2005-07-14 | Novakoff James L | Method for conducting pharmacogenomics-based studies |
SG158150A1 (en) | 2004-12-21 | 2010-01-29 | Centocor Inc | Anti-il-12 antibodies, epitopes, compositions, methods and uses |
BRPI0710155A2 (pt) | 2006-04-10 | 2011-08-23 | Infectious Disease Res Inst Inc | compostos e métodos para diagnóstico e tratamento de leishmaniose |
EP2291394B1 (en) | 2008-07-03 | 2017-03-15 | Infectious Disease Research Institute | Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
ES2728865T3 (es) | 2013-03-28 | 2019-10-29 | Infectious Disease Res Inst | Vacunas que comprenden polipéptidos de Leishmania para el tratamiento y el diagnóstico de la leishmaniasis |
CN103837687A (zh) * | 2014-03-10 | 2014-06-04 | 青岛康立泰药业有限公司 | 使用具有白细胞介素-12受体的细胞检测重组人白细胞介素-12体外活性的方法及应用 |
US10765724B2 (en) | 2016-03-29 | 2020-09-08 | Janssen Biotech, Inc. | Method of treating psoriasis with increased interval dosing of anti-IL12/23 antibody |
TW201922780A (zh) * | 2017-09-25 | 2019-06-16 | 美商健生生物科技公司 | 以抗il12/il23抗體治療狼瘡之安全且有效之方法 |
EP3793521A4 (en) | 2018-05-18 | 2022-02-23 | Janssen Biotech, Inc. | SAFE AND EFFECTIVE METHOD OF TREATING LUPUS WITH AN ANTI-IL12/IL23 ANTIBODY |
DK3883606T5 (da) | 2018-09-24 | 2024-01-02 | Janssen Biotech Inc | Sikker og effektiv fremgangsmåde til behandling af colitis ulcerosa med anti-il12/il23-antistof |
MX2021014302A (es) | 2019-05-23 | 2022-01-04 | Janssen Biotech Inc | Metodo para tratar la enfermedad inflamatoria del intestino con una terapia de combinacion de anticuerpos contra il-23 y tnf alfa. |
-
1995
- 1995-04-24 PT PT95918291T patent/PT804581E/pt unknown
- 1995-04-24 AT AT95918291T patent/ATE206163T1/de not_active IP Right Cessation
- 1995-04-24 CA CA002188543A patent/CA2188543A1/en not_active Abandoned
- 1995-04-24 AU AU24276/95A patent/AU695273B2/en not_active Ceased
- 1995-04-24 EP EP95918291A patent/EP0804581B1/en not_active Expired - Lifetime
- 1995-04-24 NZ NZ285238A patent/NZ285238A/en not_active IP Right Cessation
- 1995-04-24 JP JP52782295A patent/JP3350551B2/ja not_active Expired - Fee Related
- 1995-04-24 WO PCT/US1995/005064 patent/WO1995029239A2/en active IP Right Grant
- 1995-04-24 KR KR1019960705904A patent/KR100358271B1/ko not_active IP Right Cessation
- 1995-04-24 DE DE69522965T patent/DE69522965T2/de not_active Expired - Fee Related
- 1995-04-24 ES ES95918291T patent/ES2161883T3/es not_active Expired - Lifetime
- 1995-04-24 BR BR9507505A patent/BR9507505A/pt not_active Application Discontinuation
- 1995-04-24 CN CN95193405A patent/CN1149887A/zh active Pending
- 1995-05-30 US US08/454,036 patent/US5876966A/en not_active Expired - Lifetime
-
1996
- 1996-10-21 NO NO964468A patent/NO964468L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0804581B1 (en) | 2001-09-26 |
JP3350551B2 (ja) | 2002-11-25 |
PT804581E (pt) | 2002-02-28 |
AU695273B2 (en) | 1998-08-13 |
ATE206163T1 (de) | 2001-10-15 |
CA2188543A1 (en) | 1995-11-02 |
JPH09512172A (ja) | 1997-12-09 |
WO1995029239A3 (en) | 1995-11-30 |
CN1149887A (zh) | 1997-05-14 |
EP0804581A1 (en) | 1997-11-05 |
US5876966A (en) | 1999-03-02 |
DE69522965D1 (de) | 2001-10-31 |
NO964468L (no) | 1996-12-20 |
BR9507505A (pt) | 1997-09-02 |
NZ285238A (en) | 1997-12-19 |
NO964468D0 (no) | 1996-10-21 |
KR970702367A (ko) | 1997-05-13 |
KR100358271B1 (ko) | 2003-03-15 |
WO1995029239A2 (en) | 1995-11-02 |
DE69522965T2 (de) | 2002-04-04 |
MX9604993A (es) | 1998-05-31 |
AU2427695A (en) | 1995-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2161883T3 (es) | Compuestos y metodos para la estimulacion y aumento de las respuestas inmunes protectoras y la produccion de il-2. | |
AU2080988A (en) | Esters of 13-trans-retinoic acid | |
IT1223709B (it) | Anelli terapeutici e procedimento per la loro produzione | |
ES2058592T3 (es) | El uso de sustancias activas fisiologicamente para la fabricacion de medicamentos para enfermedades cerebrales y neuronales. | |
ZA848369B (en) | Pharmaceutical compositions containing bilobalid for the treatment of neuropathies | |
CA2026783A1 (en) | Use of il-7 in providing medications for stimulation of platelet production | |
ZA913910B (en) | Use of baclofen for obtaining medicaments for the treatment of angina pectoris | |
DE3588023D1 (de) | Mittel zur Behandlung von Herzerkrankungen. | |
ATA91797A (de) | Eine das vwf-propeptid enthaltende pharmazeutische präparation | |
ES2063060T3 (es) | Benzamida contra enfermedades cognoscitivas. | |
DE3681581D1 (de) | 4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamine und 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamine. | |
IT8721115A0 (it) | Fitopreparato per la cura di affezioni cutanee. | |
CS675086A2 (en) | Zpusob vyroby novych derivatu 1a 13 bromergolinu | |
IT1288399B1 (it) | Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi | |
PH24094A (en) | 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants | |
EP0301449A3 (en) | Enantiomers of propafenone-containing therapeutic agents | |
EP0158880A3 (en) | Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them | |
JPS5753475A (en) | Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same | |
NO890681D0 (no) | Fremgangsmaate for fremstilling av alkanoyl- og aroyloxazoloner. | |
AR240063A1 (es) | Procedimiento para la produccion del activador del plasminogeno del tejido humano mediante el cultivo de la cepa de celulas registrada como kym-sf ifo 50135. | |
AU1162788A (en) | Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases | |
IT1209508B (it) | Nuovi medicinali per il trattamento di malattie cardiache. | |
RO89901A2 (ro) | Metoda pentru stimularea luminoasa a irisului in scop terapeutic si de cercetare si aparat pentru aplicarea acesteia | |
IT8520736A0 (it) | Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari. | |
UA7955A (uk) | Спосіб лікування туберкульозу легенів |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 804581 Country of ref document: ES |